Stocks

Stocks Market News

20 stories
tradingview

Sky completed ATM sales of ~4.41M shares raising $13.53M

Sky completed at-the-market sales of approximately 4,408,137 shares, raising about $13,528,940 in net proceeds.Key Highlights:Original SEC Filing: Sky Quarry Inc. [ SKYQ ] - 8-K - Jul. 30, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with…

TradingView en_IN
StocksUS
tradingview

Vail Resorts appoints William Hornbuckle to board, effective Aug 3, 2026

Vail Resorts appointed William Hornbuckle to its Board of Directors, effective August 3, 2026, increasing the board size from nine to ten members.Original SEC Filing: VAIL RESORTS INC [ MTN ] - 8-K - Jul. 30, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying importa…

TradingView en_IN
StocksUS
tradingview

Vincent Retort to Retire as Lumentum Executive VP of Global Reliability & Quality

Lumentum announced that Vincent Retort will retire as Executive Vice President, Global Reliability & Quality, effective October 2026, and will provide consulting services for two years thereafter.Original SEC Filing: Lumentum Holdings Inc. [ LITE ] - 8-K - Jul. 30, 2026This is an AI-powered summary…

TradingView en_IN
StocksUS
tradingview

Global Partners redeems all Series B preferred units for $75.0M, paid July 30, 2026

Global Partners redeemed all 3,000,000 Series B preferred units at $25.00 per unit and paid accrued cash distribution.Key Highlights:Original SEC Filing: GLOBAL PARTNERS LP [ GLP ] - 8-K - Jul. 30, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informat…

TradingView en_IN
StocksUS
tradingview

Genprex Disclosed Failure to Satisfy a Continued Listing Rule or Standard

On July 29, 2026, a Nasdaq Hearings Panel granted the company an exception to continue its Nasdaq listing related to the $1.00 minimum bid price rule (Rule 5550(a)(2)). Genprex must demonstrate compliance by July 29, 2026 and then maintain a closing bid of at least $1.00 for each trading day throug…

TradingView en_IN
StocksUS
tradingview

Esquire Financial Holdings Declares $0.20 Quarterly Dividend Payable Sept. 1

Esquire Financial Holdings declared a regular quarterly dividend of $0.20 per share.Key Highlights:Original SEC Filing: Esquire Financial Holdings, Inc. [ ESQ ] - 8-K - Jul. 30, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source…

TradingView en_IN
StocksUS
tradingview

Huntsman posts Q2 2026 revenue $1.663B, adjusted EBITDA $120M, net loss $6M

Huntsman reported second-quarter 2026 results with revenue of $1,663 million and adjusted EBITDA of $120 million. The company recorded a net loss attributable to Huntsman of $6 million (diluted loss per share $0.03) and reported adjusted net income of nil for the quarter. Management highlighted vol…

TradingView en_IN
StocksUS
tradingview

Asure Software Q2 2026: Revenue $37.1M (+23% YoY), Adjusted EBITDA $7.7M

Asure Software reported second-quarter 2026 revenue of $37.1 million, up 23% year-over-year, with recurring revenue of $34.0 million, up 19% year-over-year. The company posted a net loss of $4.4 million for the quarter while adjusted EBITDA was $7.7 million. Management reiterated focus on product a…

TradingView en_IN
StocksUS
tradingview

Annexon Secures Up to $200 Million Term Loan Facility With Oxford Finance

Annexon entered into a Loan and Security Agreement to access up to $200.0 million in term loans for working capital and general corporate purposes. The facility includes an initial $50.0 million funded at signing, up to $100.0 million in additional milestone-based tranches, and a further uncommitte…

TradingView en_IN
StocksUS
tradingview

Brain appoints Peter Pitts as Executive Chairman and Chief Strategic Regulatory Officer; Jacob Frenkel and Ibrahim Dagher to advisory consulting roles

Brain appointed Peter Pitts as Executive Chairman and Chief Strategic Regulatory Officer, while Jacob Frenkel resigned as Chairman and transitioned to a consulting advisory role and Ibrahim B. Dagher resigned as EVP & Chief Medical Officer and moved to a consulting role.Original SEC Filing: BRAINST…

TradingView en_IN
StocksUS